Share on StockTwits

Vectura Group PLC (LON:VEC)‘s stock had its “buy” rating restated by stock analysts at Oriel Securities Ltd in a report issued on Thursday. They currently have a GBX 207 ($3.44) target price on the stock. Oriel Securities Ltd’s price target suggests a potential upside of 53.05% from the company’s current price.

Vectura Group PLC (LON:VEC) opened at 136.75 on Thursday. Vectura Group PLC has a one year low of GBX 101.00 and a one year high of GBX 171.50. The stock’s 50-day moving average is GBX 138.0 and its 200-day moving average is GBX 141.0. The company’s market cap is £546.8 million.

Other equities research analysts have also recently issued reports about the stock. Analysts at FinnCap reiterated a “buy” rating on shares of Vectura Group PLC in a research note on Thursday. They now have a GBX 202 ($3.35) price target on the stock. Separately, analysts at Canaccord Genuity reiterated a “buy” rating on shares of Vectura Group PLC in a research note on Thursday, August 21st. They now have a GBX 192 ($3.19) price target on the stock. Finally, analysts at N+1 Singer reiterated a “hold” rating on shares of Vectura Group PLC in a research note on Tuesday, August 19th. They now have a GBX 135 ($2.24) price target on the stock. Three investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Vectura Group PLC presently has an average rating of “Buy” and a consensus target price of GBX 178 ($2.95).

Vectura Group plc (LON:VEC) is a developer of therapies principally for the treatment of respiratory diseases.

Receive News & Ratings for Vectura Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vectura Group PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.